Wix.com, Ltd., a Tel Aviv, Israel-based global website creation company, launched Wix Capital, its own venture capital arm.
LIGC, an Israeli maker of Laser-Induced Graphene filters (LIG), raised $3M in Series A funding.
Hetz Ventures, a Tel Aviv, Israel-based venture capital firm for early-stage investments, closed its second flagship fund, at $77m.
Today, Team8*, a company-building venture group backed with strategic funding from Microsoft, Walmart, Barclays and Moody’s, among others, launched Team8 Fintech, a practice focused on founding and scaling transformative fintech companies.
Varada, a Tel Aviv, Israel-based big data query acceleration company, closed a $12m Series A round of funding.
Sternum, a Tel Aviv, Israel-based IoT cybersecurity company providing embedded protection and real-time visibility for connected devices, raised $6.5m in Series A funding.
Plantt, a Tel Aviv, Israel-based Customer Experience Optimization Platform, completed its $1M seed funding round.
Greenfield Partners, a Tel Aviv, Israel-based investment firm, closed a $150m fund.
Orasis Pharmaceuticals, a Herzliya, Israel-based ophthalmic pharmaceutical company focused on developing an innovative pharmaceutical solution for the treatment of presbyopia symptoms, closed a $30m Series C financing.
Capitolis, a SaaS platform that drives financial resource optimization for capital markets, completed a strategic investment from Citi, J.P. Morgan and State Street.
Pcysys, a Tel-Aviv, Israel-based cybersecurity validation company, completed a $25m Series B funding.
ENvizion, a Tel Aviv, Israel-based FDA 510(k) cleared leader in enteral feeding placement navigation technology, raised $18m in funding.
Vessi Medical, a Misgav, Israel-based developer of a cryoablation solution for superficial bladder cancer, secured $1.7m in funding.
proteanTecs, a Haifa, Israel-based developer of Deep Data solutions for electronics’ health & performance monitoring, closed a $45M growth equity financing round.
Nano-X Imaging LTD, a Neve Ilan, Israel-based innovative medical imaging technology company, announced the pricing of its initial public offering of 9,178,744 ordinary shares at a price to the public of US$18 per share.